ALQGC fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ALQGC does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company